Pompe Disease Serum

All filters

Format

Format

Format
Volume / Size

Volume / Size

Volume / Size
Condition

Condition

Condition

Start typing to see matching condition.

Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

6 lots match
6 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Pompe Disease Serum 80186 151725 Female 46-60 Caucasian Frozen 1 mL 8 — Pombiliti + Opfolda 20mg/kg + 260mg, Q 2 weeks Pompe Disease United States 2026 — — — — — — — — — 219410; 219416; 219413; 219417; 219414; 219412; 219415; 219411Serum1.0 MLPompe DiseasePompe DiseaseNo30.78NoNoNoNoNoNOYesStoredIn Stock
$667
Pompe Disease Serum 80185 151660 Female 46-60 Caucasian Frozen 1 mL 8 — Ventolin HFA 90 mcg per puff, 2 puffs 4 to 6 hours PRN, asthma, currently taking-; Buspar 10 mg TID, anxiety, currently taking-; Venlafaxine 50 mg TID, depression, currently taking-; Xanax 0.5mg Q8 PRN, anxiety, currently taking-; Norco 7.5mg/325mg Q6 PRN, pain, currently taking-; Ambien 10mg Q night, insomnia, currently taking-; Cyclobenzaprine 10 mg Q8 hours PRN, pain, currently taking-; Benadryl 50mg PRN, itching from narcotics, currently taking-; Nexviazyme 20mg/kg IV Q 2 weeks, Pompe, currently taking-(pre meds for infusions Singulair, Zyrtec, Solu-Medrol) Pompe Disease United States 2026 — — — — — — — — — 218815; 218814; 218813; 218812; 218811; 218810; 218809; 218808Serum1.0 MLPompe DiseasePompe DiseaseYesSeasonal24.59NoNoNoNo101YesNOYesStoredIn Stock
$667
Pompe Disease Serum 80090 145398 Female 46-60 Caucasian Frozen 1 mL 7 — Synthroid 112mcg QD currently taking Sertraline 25mg QD ( used to be on 50mg decreased ), currently taking, Nexviazyme infusions 20mg/kg, ERT replacement, Q 2 weeks, next dose Pompe Disease United States 2026 — — — — — — — — — 217302; 217301; 217297; 217300; 217299; 217298; 217296Serum1.0 MLPompe DiseasePompe DiseaseYesGluten, Dairy19.97NoNoNoNoNoNOYesStoredIn Stock
$667
Pompe Disease Serum 80033 150928 Male 18-30 Caucasian Frozen 1 mL 8 — Adderall 25 mg QD, ADHD, currently taking Adderall 10mg PRN, ADHD, currently taking ( only takes PRN 1-2x month) Nexviazyme infusion 20mg/kg, next dose will be on, infusions every 2 weeks Pompe Disease United States 2026 — — — — — — — — — 217045; 217046; 217043; 217047; 217044; 217042; 217041; 217040Serum1.0 MLPompe DiseasePompe DiseaseNo33.74NoNoNoNoNoYESYesStoredIn Stock
$667
Pompe Disease Serum 80030 151069 Male 61+ Caucasian Frozen 1 mL 8 — Lisinopril/Hydrochlorothiazide, 20 mg / 12.5 mg, currently taking Nexviazyme currently taking, 40mg/kg IV Q 2weeks, stable dose Pompe Disease United States 2026 — — — — — — — — — 217058; 217051; 217053; 217057; 217055; 217054; 217056; 217052Serum1.0 MLPompe DiseasePompe DiseaseNo24.96NoNoNoNoYesYESYesStoredIn Stock
$667
Pompe Disease Serum 73323 145344 Male 31-45 Caucasian Frozen 1 mL 7 — Nexviazyme 20mg/kg IV q 2 weeks, currently taking Vitiligo, Pompe Disease United States 2026 — — — — — — — — — 185971; 185972; 185973; 185974; 185975; 185976; 185977Serum1.0 MLPompe DiseasePompe Disease;VitiligoNo25.03NoNoNoNoNoNONoStoredIn Stock
$667

Showing 1–6 of 6 lots

About Pompe Disease Serum

Pompe Disease Serum is sourced from consented donors with documented Pompe disease. These samples support immunoassay and proteomics research, with donor information on condition, demographics, medications and comorbidities.

Applications

  • Pompe Disease research
  • Immunoassay development
  • Serum proteomic research
  • Metabolomic research
  • Soluble-protein studies

Product Features

  • Human serum
  • Donor condition: Pompe Disease
  • Consented donor collection
  • Research Use Only (RUO)

De-identified Donor Data

  • Donor condition/diagnosis and documented clinical phenotype
  • Age, gender and race/ethnicity
  • Medications and comorbidities
  • HLA typing and CMV status
  • HIV, HBV, HCV and syphilis testing
  • ABO/Rh blood type and country of collection
  • Tobacco, alcohol, caffeine and recreational drug use

Protocols & Documentation

  • Serum Isolation

    Protocol for serum preparation from whole blood, including collection handling, clarification, and quality documentation.

    Download
  • Informed Consent Form (ICF)

    Available upon request — confirms donor consent for research use and downstream commercialization.

Serum

Where can I find your complete catalog?
How long can samples be stored?

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

What customization options are available?

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Do you offer prospective collections?

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

What is the turnaround time for custom collections?

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

Do you have samples in stock?

YES - we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

What does unique donor mean?

Each sample from a different individual - Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

Are samples collected under IRB-approved protocols?

YES - "IRB-approved collection protocols" and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

Frequently Asked Questions

×

Ask a Question

Pair with a Healthy Control

Match your Pompe Disease Serum with normal donor samples for comparison

Healthy Serum

99 In Stock
Screened normal donors · Frozen · Starting at $132
View Inventory

Need a custom Serum cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information